BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/28/2020 2:46:56 PM | Browse: 1152 | Download: 2230
Publication Name World Journal of Gastroenterology
Manuscript ID 54484
Country Germany
Received
2020-02-03 23:49
Peer-Review Started
2020-02-03 23:49
First Decision by Editorial Office Director
2020-02-27 03:16
Return for Revision
2020-02-27 03:16
Revised
2020-05-24 22:06
Publication Fee Transferred
Second Decision by Editor
2020-06-17 09:16
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2020-06-17 20:53
Articles in Press
2020-06-17 20:53
Edit the Manuscript by Language Editor
2020-07-07 03:30
Typeset the Manuscript
2020-07-28 07:31
Publish the Manuscript Online
2020-07-28 14:46
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Review
Article Title Differential regulation of JAK/STAT-signaling in patients with ulcerative colitis and Crohn’s disease
Manuscript Source Invited Manuscript
All Author List Friederike Cordes, Dirk Foell, John Nik Ding, Georg Varga and Dominik Bettenworth
ORCID
Author(s) ORCID Number
Friederike Cordes http://orcid.org/0000-0002-0376-0764
Dirk Foell http://orcid.org/0000-0002-1946-3916
John Nik Ding http://orcid.org/0000-0002-6232-1948
Georg Varga http://orcid.org/0000-0002-1547-8766
Dominik Bettenworth http://orcid.org/0000-0002-1435-4825
Funding Agency and Grant Number
Corresponding Author Friederike Cordes, MD, Doctor, Doctor, Department of Medicine B for Gastroenterology and Hepatology, University Hospital Münster, Albert-Schweitzer-Campus 1, Münster D-48149, Germany. annafriederike.cordes@ukmuenster.de
Key Words Janus kinase; Signal transducer and activator of transcription; JAK/STAT pathway; Inflammatory bowel disease; Ulcerative colitis; Crohn’s disease; JAK/STAT inhibition; Tofacitinib
Core Tip The pan-Janus kinase (JAK)-inhibitor tofacitinib is efficacious in patients with active ulcerative colitis (UC) but not Crohn’s disease (CD), which hints at different contribution of JAK-signaling in both entities. In this review available data on differential JAK/signal transducer and activator of transcription (STAT)-signaling in UC and CD were analyzed. Literature review identified differential cell-subset specific JAK/STAT-signaling including increased T-cell-associated STAT1 signaling in CD and STAT6 signaling in UC, while in myeloid cells inflammatory STAT1 was increased in UC compared with CD indicating a less inflammatory role of myeloid cells in CD. Development of JAK/STAT-inhibitors with specific targeting of associated inflammatory pathways might further improve efficacy and safety profiles of this drug class.
Publish Date 2020-07-28 14:46
Citation Cordes F, Foell D, Ding JN, Varga G, Bettenworth D. Differential regulation of JAK/STAT-signaling in patients with ulcerative colitis and Crohn’s disease. World J Gastroenterol 2020; 26(28): 4055-4075
URL https://www.wjgnet.com/1007-9327/full/v26/i28/4055.htm
DOI https://dx.doi.org/10.3748/wjg.v26.i28.4055
Full Article (PDF) WJG-26-4055.pdf
Full Article (Word) WJG-26-4055.docx